Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06366269 · ClinicalTrials.gov registry record · NA
Acupuncture First for IC/BPS
A NA study of Interstitial Cystitis and Bladder Pain Syndrome, sponsored by University Hospitals Cleveland Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT06366269: Recruiting NA study of Interstitial Cystitis and Bladder Pain Syndrome, sponsored by University Hospitals Cleveland Medical Center.
NCT06366269 is a NA study of Interstitial Cystitis and Bladder Pain Syndrome that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 34 participants, below the 361-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06366269, a NA study of Interstitial Cystitis and Bladder Pain Syndrome, is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if acupuncture in addition to behavioral changes can better treat in women with bladder pain syndrome (also known as interstitial cystitis) that have not received other treatments. The main question it aims to answer is: Does acupuncture improve pain symptoms on the Interstitial Cystitis Index? Researchers will compare six (6) weeks behavioral management alone to behavioral management and acupuncture. Participants will * complete surveys about their bladder pain symptoms * make behavioral changes that have been shown to improve bladder pain symptoms * attend six (6) weekly acupuncture sessions * attend six (6) weekly physical therapy sessions after finishing acupuncture
Primary Outcome
Validated 8-item questionnaire with reported scores ranging 0-37. Higher scores are consistent with worse symptoms.
Conditions Studied
Interventions
- OTHER Acupuncture
- OTHER Physical therapy
- BEHAVIORAL Behavioral management
Study Locations (1)
Ohio
- University Hospitals - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2025-01-21 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT06366269 shows while recruiting
NCT06366269 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 361-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Interstitial Cystitis appearing as the primary indexed condition, and to 3 interventions - of which Acupuncture is the first listed.
NCT06366269 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06366269 about?
NCT06366269 is a clinical study titled "Acupuncture First for IC/BPS". The goal of this clinical trial is to learn if acupuncture in addition to behavioral changes can better treat in women with bladder pain syndrome (also known as interstitial cystitis) that have not received other treatments. The main question it aims to answer is: Does acupuncture improve pain symp...
What is the current status of trial NCT06366269?
This trial is currently recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2025-01-21. Estimated completion is 2026-10.
What conditions does trial NCT06366269 study?
This clinical trial studies the following conditions: Interstitial Cystitis, Bladder Pain Syndrome.
What interventions are being tested in trial NCT06366269?
The interventions under investigation include: Acupuncture (OTHER), Physical therapy (OTHER), Behavioral management (BEHAVIORAL).
Who is sponsoring clinical trial NCT06366269?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06366269 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Cystitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06366269's enrollment target sits among peer trials
34 19th of 26 higher than 8 of 26 other Interstitial Cystitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Interstitial Cystitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
RECRUITING · NA
-
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
RECRUITING · NA
-
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
RECRUITING · NA
-
Investigation of PEMF Therapy for Female Patients With IC/BPS
RECRUITING · NA
-
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
ACTIVE NOT RECRUITING · NA
-
Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI